FENTANYL Sublingual (AbstralĀ®)
Clinical Indication
Breakthrough cancer pain in patients already on opioids. Palliative care in line with guidance
Comments
Conditional on recommendation from palliative care team.
See:Ā Palliative care – drugs for use only after specialist recommendation
Date of classification
June 2015
Green
Medicines which could be started in any health care setting and do not require oversight by a specialist and which primary care would have full responsibility for prescribing and monitoring.